Prevention and early diagnosis of diabetic skin complications using optical and biophotonic imaging in Niger.
Adamou Soli Idrissa1, Mahamane Sani M. Aminou1,4, Moussa Issoufou Djibrillou1,2, Mamane Barga Aboubacar1,4, Salissou Laouali2,3, Ali Ada5.
1. Radio-isotopes Institute, Abdou Moumouni University, Niamey, Niger;
2. Faculty of Health Sciences, Abdou Moumouni University, Niamey, Niger;
3. National Hospital of Niamey;
4. Reference General Hospital of Niamey;
5. Magori Policlinic of Niamey, Niger.
Abstract
The mean objective is to set up a laboratory for biophotonics and optics in human health, in particular for measuring skin fluorescence in diabetics in Niger.
In Niger, with a prevalence of 2.7% for a population of 26,000,000, diabetes is a serious public health problem, not only because of its prevalence, but also because of its frequent and serious metabolic complications and degenerations.
Diabetes mellitus is the largest single component of non-communicable diseases, which today rank ahead of infectious diseases in Africa. According to forecasts by the World Health Organization (WHO), diabetes will fall from eighth to seventh place on the list of most common causes of death, with a 54% increase in mortality in 2030 compared with 2010.
One-third of diabetes patients have complications in the form of skin lesions, the most serious being chronic ulcers that heal very slowly, increasing the risk of infection and amputation. Diabetes increases the risk of cardiovascular disease, retinopathy (35.8%), leading to blindness, neuropathy (12%), and nephropathy (6%).
The clinical course and complications of diabetes are widely studied using a variety of physical methods, including optical methods, which often enable non-invasive monitoring of key biological tissue parameters in real time.
Keywords: Diabetes, optical, biophotonics, fluorescence
Speaker
ADAMOU SOLI Idrissa
Abdou Moumouni University
Niger
Discussion
Ask question
